Dr. Reddy’s Balasubramanian on growth engines
Dinakaran (Dina) Balasubramanian, head of commercial strategy and insights for biologics at Dr. Reddy’s Laboratories, spoke with Chain Drug Review about his role at the drug maker and how specialty generic drugs and biosimilars are fueling growth for it. CDR: What are your responsibilities now with Dr. Reddy’s Laboratories? BALASUBRAMANIAN: One of my primary responsibilities